Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Depression

Decline in estradiol levels precipitates depression in susceptible women

Depression-prone women who were switched from estradiol to placebo patches experienced a significant increase in depressive symptoms

Source: PHOTOTAKE Inc. / Alamy

Depression-prone women who were switched from estradiol to placebo patches experienced a significant increase in depressive symptoms

Depression increases in frequency in women undergoing the menopause. This has been suggested to reflect the perimenopausal decline in estradiol levels; consequently, estradiol therapy may help reduce perimenopausal depression (PMD) risk.

This hypothesis has now been tested for the first time, with positive results. Two groups of asymptomatic postmenopausal women — 26 with past PMD responsive to hormone therapy and 30 with no history of depression — received transdermal estradiol for three weeks before being randomised to receive estradiol or placebo skin patches for three weeks.

None of the women reported depressive symptoms during estradiol use. However, depression-prone women who were switched from estradiol to placebo patches experienced a significant increase in depressive symptoms. “Normal changes in ovarian estradiol secretion can trigger an abnormal behavioural state in susceptible women,” the researchers conclude in JAMA Psychiatry[1] (online, 27 May 2015). 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068699

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.